RenovoRx

Yahoo Finance • 9 days ago

RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites

First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center Join the University of Vermont Cancer Center as Participating... Full story

Yahoo Finance • 23 days ago

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th

MOUNTAIN VIEW, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented,... Full story

Yahoo Finance • 30 days ago

Curious about the stocks that are showing activity after the closing bell on Wednesday?

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. [postmarket] GAINERS TICKER CHANGE COMMENT... Full story

Yahoo Finance • 2 months ago

RenovoRx expands commercial footprint to 13 cancer centers

MOUNTAIN VIEW, Calif. - RenovoRx, Inc. (NASDAQ:RNXT), a medical device company with a market capitalization of $44.6 million and strong balance sheet showing more cash than debt, has expanded its commercial footprint to 13 cancer centers a... Full story

Yahoo Finance • 2 months ago

RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire

RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers approved to purchase RenovoCath Four active cancer center customers are currently purchasing and have made repeat o... Full story

Yahoo Finance • 3 months ago

Kemira Q1 2025 presentation: Solid profitability maintained amid softer market

Introduction & Market Context Finnish chemicals company Kemira reported its first quarter 2025 results on April 25, demonstrating resilience in a challenging market environment. Despite facing increased market uncertainty and softer deman... Full story

Yahoo Finance • 3 months ago

RenovoRx shareholders elect directors and approve incentive plan amendments

RenovoRx , Inc. (NASDAQ:RNXT) announced the results of its 2025 annual meeting of stockholders held Tuesday. According to a press release statement based on the company’s SEC filing, shareholders voted on three proposals. First, all nomin... Full story